Alex Livingstone-Learmonth – PharmaTimes

Cambridge Cognition has announced Alex Livingstone-Learmonth as CCO

Cambridge Cognition has announced the appointments of Alex Livingstone-Learmonth as Chief Commercial Officer and Annabelle Miles as Head of Marketing.

These additions mark a significant step as the company continues strengthening its senior leadership team in pursuit of its ambitious growth strategy.

Alex joins Cambridge Cognition with a wealth of sector experience, having worked in the clinical trial technology, services and solutions industry for over 20 years.

Having previously held the role of Vice President at Calyx and Signant Health (initially CRF Health), Alex’s background complements Cambridge Cognition’s commercial model and his experience in promoting clinical trial solutions will be instrumental as the Group continues to focus on delivering profitable growth.

Annabelle started her career at M&C Saatchi and McCann Worldwide, accumulating over ten years of experience in advertising and marketing.

During her tenure at FundamentalVR, a health VR start-up, she established a comprehensive marketing function over five years. Her most recent position at Huma involved spearheading a results-driven lead-generation strategy for marketing healthcare solutions and clinical trials.

Alex and Annabelle will play vital roles in supporting the Company’s growth strategy, implementing processes to build the orderbook, increasing awareness and brand exposure for our market leading offering and technology.